Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/1677-5449.0069
Jornal Vascular Brasileiro
Review Article

Importance of GLUT1 in differential diagnosis of vascular anomalies

Importância da GLUT1 no diagnóstico diferencial das anomalias vasculares

Tiago João da Silva Filho; Denise Hélen Imaculada Pereira de Oliveira; Ilnara de Souza Moura; Layssa Karolinne da Silva Medeiros; Amanda Katarinny Goes Gonzaga; Veruska Lima Moura Brasil; Lélia Maria Guedes Queiroz

http://dx.doi.org/10.1590/1677-5449.0069 J Vasc Bras, vol.14, n2, p.168-176, 2015
PDF English
PDF Português
Downloads: 0
Views: 1264

Abstract

Vascular anomalies (VAs) include a group of distinct lesions, such as vascular system congenital malformations, as well as benign and malignant vascular tumors. These lesions may present similar clinical and histopathological features, leading to mistaken diagnoses and incorrect treatment choices. It is important that professionals responsible for monitoring the development of VAs conduct precise investigations and use the appropriate terminology. The human glucose transporter protein isoform 1 (GLUT1) has been proposed as a tool to aid in differential diagnosis between different VAs, given that it is a sensitive and specific marker for identification of infantile hemangiomas (HIs) in any organ. This article presents a review of the literature on this protein as an effective tool for identification and possible differential diagnosis between several VAs.

Keywords

vascular malformations, hemangioma, diagnosis differential

Resumo

As anomalias vasculares (AVs) incluem um grupo de lesões distintas, como as más formações congênitas e os tumores vasculares benignos ou malignos. Estas lesões podem apresentar características clínicas e histopatológicas semelhantes, ocasionando equívocos diagnósticos e terapêuticos. Uma investigação precisa e o uso de terminologia adequada são fundamentais para as decisões do profissional responsável pelo acompanhamento da evolução de uma AV. A isoforma 1 da proteína humana transportadora de glicose (GLUT1) tem sido proposta como uma ferramenta auxiliar para o estabelecimento de diagnóstico diferencial entre AVs, uma vez que representa um marcador sensível e específico para a identificação de hemangiomas da infância de qualquer órgão. Este estudo objetiva fazer uma revisão da literatura acerca desta proteína como ferramenta eficaz na identificação e no possível diagnóstico diferencial entre as diversas AVs.

Palavras-chave

más formações vasculares, hemangioma, diagnóstico diferencial

References

Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg.. 1982;69(3):412-22.

Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol.. 1997;13:375-423.

Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy. Arch Dermatol.. 2000;136(7):905-14.

Enjolras O, Wassef M, Chapot R. Introduction: ISSVA classification. 1997.

Tucci FM, De Vincentiis GC, Sitzia E, Giuzio L, Trozzi M, Bottero S. Head and neck vascular anomalies in children. Int J Pediatr Otorhinolaryngol.. 2009;73(Supl 1):S71-6.

Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med.. 1999;341(3):173-81.

Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg.. 2000;37(8):517-84.

North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1. Hum Pathol.. 2000;31(1):11-22.

Hiraki PY, Goldenberg DC. Diagnosis and treatment of infantile hemangioma. Rev. Bras. Cir. Plást.. 2010;25(2):388-97.

Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg.. 2000;37(8):518-84.

Gontijo B, Silva CMR, Pereira LB. Hemangiomaofinfancy. An Bras Dermatol.. 2003;78:651-73.

Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg.. 2011;127(1):347-51.

Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol.. 2012;47(2):106-17.

Spiteri Cornish K, Reddy AR. The use of propranolol in the management of periocular capillary haemangioma--a systematic review. Eye (Lond).. 2011;25(10):1277-83.

Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg.. 2002;110(2):572-88.

Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, april 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermato.. 2005;22(5):383-406.

Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy. Arch Dermatol.. 2002;138(12):1567-76.

Werner JA, Dünne AA, Folz BJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol.. 2001;258(3):141-9.

Fevurly, RD, Fishman, SJ. Vascular anomalies in pediatrics. Surg Clin North Am.. 2012;92(3):769-800.

North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol.. 2001;137(5):559-70.

Ballah D, Cahill AM, Fontalvo L,. Vascular anomalies: what they are, how to diagnose them, and how to treat them. Curr Probl Diagn Radiol.. 2011;40(6):233-47.

Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB, The Guidelines/Outcomes Committee. Guidelines of care for hemangiomas of infancy. J Am Acad Dermatol.. 1997;37(4):631-7.

Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg.. 2009;20(Supl 1):678-84.

Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells.. 2006;24(6):1605-12.

Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma. J Am Acad Dermatol.. 2004;50(6):875-82.

North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC Jr. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol.. 2001;137(12):1607-20.

Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Curr Genomics.. 2007;8(2):113-28.

Widdas WF. Old and new concepts of the membrane transport for glucose in cells. Biochim Biophys Acta.. 1988;947(3):385-404.

Joost HG, Bell GI, Best JD,. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab.. 2002;282(4):E974-6.

Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch.. 2004;447(5):513-5.

Machado UF, Schaan BD, Seraphim PM. Glucose transporters in the metabolic syndrome. Arq Bras Endocrinol Metabol.. 2006;50(2):177-89.

Wu X, Freeze HH. GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics.. 2002;80(6):553-7.

Scheepers A, Joost HG, Schürmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr.. 2004;28(5):364-71.

Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol.. 2001;18(4):247-56.

Thorens B, Charron MJ, Lodish HF. Molecular physiology of glucose transporters. Diabetes Care.. 1990;13(3):209-18.

Kasanicki MA, Pilch PF. Regulation of glucose-transporter function. Diabetes Care.. 1990;13(3):219-27.

Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H. Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochem Biophys Res Commun.. 1990;173(1):67-73.

Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer.. 1997;80(6):1046-51.

Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT). Br J Nutr.. 2003;89(1):3-9.

Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol.. 2004;35(2):200-9.

Johann AC, Salla JT, Gomez RS, Aguiar MC, Gontijo B, Mesquita RA. GLUT-1 in oral benign vascular lesions. Oral Dis.. 2007;13(1):51-5.

Osaki TH, Jakobiec FA, Mendoza PR, Lee Y, Fay AM. Immunohistochemical investigations of orbital infantile hemangiomas and adult encapsulated cavernous venous lesions (malformation versus hemangioma). Ophthal Plast Reconstr Surg.. 2013;29(3):183-95.

Oliveira DH, Silveira EJ, Medeiros AM, Alves PM, Queiroz LM. Study of the etiopathogenesis and differential diagnosis of oral vascular lesions by immunoexpression of GLUT-1 and HIF-1α. J Oral Pathol Med.. 2014;43(1):76-80.

Tasnádi G. Epidemiology and etiology of congenital vascular malformations. Semin Vasc Surg.. 1993;6(4):200-3.

Al-Adnani M, Williams S, Rampling D, Ashworth M, Malone M, Sebire NJ. Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system. J Clin Pathol.. 2002;59(12):1278-82.

Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin.. 1998;16(3):455-88.

Freitas TM, Miguel MC, Silveira EJ, Freitas RA, Galvão HC. Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas. Exp Mol Pathol.. 2005;79(1):79-85.

Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg.. 2005;58(3):348-52.

Seo J, Utumi ER, Zambon CE,. Escleroterapia de hemangioma labial. Rev Odonto.. 2009;17(34):106-12.

Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis.. 2010;16(5):405-18.

Vasconcelos MG, Alves PM, Vasconcelos RG, Silveira ÉJ, Medeiros AM, Queiroz LM. Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas. Eur Arch Otorhinolaryngol.. 2011;268(8):1213-7.

Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol.. 2003;6(6):495-510.

Li Q, Yu Y, Bischoff J, Mulliken JB, Olsen BR. Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol.. 2003;201(2):296-302.

Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol.. 2004;28(5):559-68.

Drut RM, Drut R. Extracutaneous infantile haemangioma is also Glut1 positive. J Clin Pathol.. 2004;57(11):1197-200.

Nguyen VA, Fürhapter C, Romani N, Weber F, Sepp N. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol.. 2004;35(6):739-44.

Itinteang T, Tan ST, Jia J, et al. Mast cells in infantile haemangioma possess a primitive myeloid phenotype. J Clin Pathol.. 2002;66(7):597-600.

Dyduch G, Okoń K, Mierzyński W. Benign vascular proliferations--an immunohistochemical and comparative study. Pol J Pathol.. 2004;55(2):59-64.

Srinivasan B, Ethunandan M, Van der Horst C, Markus AF. Intraosseous 'haemangioma' of the zygoma: more appropriately termed a venous malformation. Int J Oral Maxillofac Surg.. 2009;38(10):1066-70.

Patiño-Seijas B, Lorenzo-Franco F, Rey-Sanjurjo JL, González-Cuesta M, López-Cedrún Cembranos JL. Vascular Lesions: GLUT-1 expression as a diagnostic tool to discriminate tumors from malformations. J Oral Maxillofac Surg.. 2012;70(10):2333-42.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5de7f3630e88259e19e31d42 jvb Articles
Links & Downloads
1677-7301 (Electronic)
J Vasc Bras ©2024 All rights reserved.

J Vasc Bras

Share this page
Page Sections